Notification of trade primary insider

Scientific Advisor of Biotec Pharmacon, Dr. Rolf
Seljelid, has today purchased 25,000 shares in the
Company at an average price of NOK 4.00 per share.
Dr. Seljelid holds 75,000 shares after this
transaction.